Are Reckitt Benckiser Group Plc And Unilever plc The Most Solid Performers On The FTSE 100?

Reckitt Benckiser Group Plc (LON: RB) and Unilever plc (LON: ULVR) can help you sleep at night, says Harvey Jones

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

It has been a bloody six months on the FTSE 100, one that has left many big-name stocks bathed in red.

BP and Royal Dutch Shell are down 20% and 15% respectively in that time. Tesco and J Sainsbury are both down more than 20%.

BHP Billiton and Rio Tinto are down 32% and 15% respectively. GlaxoSmithKline is down 10%.

All are solid blue-chips with red faces, confirming that no stock, no matter how big, is ever safe.

The Goodies

Although right now, Reckitt Benckiser Group (LSE: RB.) and Unilever (LSE: ULVR) (NYSE: UL.US) look like happy exceptions.

Despite the odd shortlived swing, these stocks keep delivering the (household) goods, year after year.

Whether you measure their performance over five years, one year, six months or one week, they have delivered a positive return.

Can this really continue?

Price Worth Paying

I’ve always resisted buying these two stocks, because both have been expensive by conventional metrics, while their yields disappoint.

It’s the same story today. RB trades at more than 22 times earnings and yields a little over 2.5%.

Unilever trades at 21 times earnings and yields a slightly juicier 3.3%.

That is all notably below the FTSE 100 average of around 15 times earnings on a yield of 3.5%.

But as they say, you get what you pay for.

Emerging Worries

Another reason I was sceptical about these two companies was the slowdown in the emerging markets, which I feared could turn into a full-blown retreat in China.

This was RB and Unilever’s big shot at future growth, as emerging market consumers loaded up their shopping trolleys with Western-branded processed foods, household goods, and health and beauty items.

The ever-strengthening dollar could put a further squeeze on emerging markets spend, but investors aren’t worried for now.

Are these stocks bullet proof?

Reassuringly expensive

RB and Unilever both posted disappointing results last October, and investors were further rattled by warnings that global consumer spending was under threat. Analysts warned of slow growth future and overpriced valuations.

But the growth has continued, and both stocks still look reassuringly pricey. Brokers are a little more sceptical about Unilever, which suffers from a series of ‘sell’ and ‘underweight’ ratings, but sentiment towards RB is positive.

Unilever reports on Tuesday, with Q4 sales expected to rise by around 5%. Investors will be focused on the outlook for Europe and China, and the prospect for some much-needed dividend growth.

But right now, it is hard to find more solid investments.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Harvey Jones has no position in any shares mentioned. The Motley Fool UK has recommended GlaxoSmithKline. The Motley Fool UK owns shares of Unilever and Tesco. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Smiling white woman holding iPhone with Airpods in ear
Investing Articles

£9,000 of savings? Here’s my 3-step approach to aim for £1,794 in passive income

Christopher Ruane walks through the practical steps he would take to try and turn £9,000 into a sizeable passive income…

Read more »

Group of young friends toasting each other with beers in a pub
Investing Articles

I’d buy 29,412 shares of this UK dividend stock for £150 a month in passive income

Insiders have been buying this dividend stock, which offers an 8.5% yield. Roland Head explains why he’d choose the shares…

Read more »

Red briefcase with the words Budget HM Treasury embossed in gold
Investing Articles

Could the new UK budget spell growth for these 6 FTSE stocks? I think so!

Mark David Hartley considers six UK stocks that could enjoy growth off the back of new measures announced in the…

Read more »

Investing Articles

With a 6.6% yield, is now the right time to add this income stock to my ISA?

Our writer’s looking to boost his Stocks and Shares ISA. With this in mind, he’s debating whether to buy a…

Read more »

Dividend Shares

This blue-chip FTSE stock just fell 12.5% in a day. Is it time to consider buying?

Smith & Nephew is a well-known, blue-chip FTSE stock with a decent dividend yield. And its share price just dropped…

Read more »

Investing Articles

At 72p, the Vodafone share price looks to be at least 33% undervalued to me

Our writer looks at a number of valuation measures to determine whether the Vodafone share price reflects the fair value…

Read more »

Investing Articles

Why I’ve just sold two of the largest investments in my Stocks and Shares ISA

Stephen Wright has been making room for a new addition to his Stocks and Shares ISA. What is it and…

Read more »

Investing Articles

2 UK shares I’m avoiding like the plague in today’s stock market

Stephen Wright is a big fan of UK shares. But both the FTSE 100 and the FTSE 250 contain companies…

Read more »